Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Relypsa Inc (RLYP)

Relypsa Inc (RLYP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Relypsa Inc 100 CARDINAL WAY REDWOOD CITY CA 94063

www.relypsa.com P: 650-421-9500

Description:

Relypsa, Inc. is a pharmaceutical company focused on the development and commercialization of nonabsorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Relypsa, Inc. is headquartered in Redwood City, California.

Key Statistics

Overview:

Market Capitalization, $K 1,434,910
Shares Outstanding, K 44,840
Annual Sales, $ 18,550 K
Annual Net Income, $ -178,720 K
Last Quarter Sales, $ 5,220 K
Last Quarter Net Income, $ -83,620 K
60-Month Beta 2.19
% of Insider Shareholders 3.70%
% of Institutional Shareholders 81.85%

Growth:

1-Year Return 41.88%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.26 on 05/04/16
Next Earnings Date 08/11/16
Earnings Per Share ttm -5.77
EPS Growth vs. Prev Qtr -48.41%
EPS Growth vs. Prev Year -96.84%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RLYP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -140.22%
Return-on-Assets % -84.38%
Profit Margin % -963.45%
Debt/Equity 0.08
Price/Sales 77.35
Price/Cash Flow N/A
Price/Book 12.92
Book Value/Share 2.47
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar